YolTech raises $70.0M (China, May 2026)
$70.0M
$70MGenerated social card
Headline
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward - Endpoints News
About
YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.
Article summary
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward Endpoints News
Founder
Yuxuan Wu
CEO
Investors
Related rounds
| Jul 01, 2026 | Cobot AI | $140.0M | Series B | China |
| Jun 24, 2026 | Tectronic Maritime Space Systems | $3.0M | — | China |
| Jun 24, 2026 | Lingxi Games | — | — | China |
| Jun 16, 2026 | SiliconFlow | $294.0M | Series B | China |